--- title: "Marchex Earnings Call: Archenia Deal Fuels Aggressive Outlook" type: "News" locale: "en" url: "https://longbridge.com/en/news/296715058.md" description: "Marchex (MCHX) reported Q2 2026 revenue of $11.0M, up 3.8% sequentially. Following the July 1 Archenia acquisition, management raised Q3 revenue guidance to $16.0M–$16.5M, reflecting a ~45-50% jump. The combined AI platform aims for long-term $100M+ revenue and Rule of 30-40 metrics. However, cash declined to $8.2M due to integration costs, and risks include high customer concentration (90% from top 100 clients) and execution challenges in scaling pilot programs." datetime: "2026-08-24T00:04:07.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/296715058.md) - [en](https://longbridge.com/en/news/296715058.md) - [zh-HK](https://longbridge.com/zh-HK/news/296715058.md) generator: "portal-rs" --- # Marchex Earnings Call: Archenia Deal Fuels Aggressive Outlook Marchex ((MCHX)) has held its Q2 earnings call. Read on for the main highlights of the call. ### Summer Sale - Claim 70% Off TipRanks - Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions - Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks Marchex’s latest earnings call struck a cautiously optimistic tone, with management highlighting the transformative Archenia acquisition and a sharp lift in near‑term revenue guidance. Executives pointed to early customer wins and margin improvement potential as evidence the combined AI platform can scale profitably, while also acknowledging cash pressure, customer concentration and execution risks that investors must watch closely. ## Archenia Deal Creates Combined AI Intelligence Platform Marchex closed the Archenia acquisition on July 1, 2026, creating a combined AI‑powered conversational intelligence and performance‑based qualification platform. Management plans to sell bundled solutions that connect call insights with automated actions and measurable outcomes, positioning the company to help customers track and optimize revenue tied directly to conversations. ## Q2 Shows Modest Sequential Revenue Growth Second‑quarter 2026 revenue came in at $11.0M, up from $10.6M in Q1, a sequential increase of about 3.8%. The improvement was driven by new sales and upsells to existing customers, suggesting the legacy Marchex business is growing steadily even before Archenia’s contribution appears in reported numbers. ## Q3 Revenue Guidance Jumps on Full Archenia Quarter For Q3 2026, management guided revenue of $16.0M–$16.5M, which includes a full quarter of Archenia. That outlook implies sequential growth of roughly 45.5%–50.0% versus Q2, signaling rapid near‑term scaling for the combined platform and a step‑change in the company’s revenue base. ## Adjusted EBITDA Guidance Points To Operating Leverage The company expects Q3 adjusted EBITDA of $2.3M–$2.5M, implying an annualized run‑rate near $9.2M–$10.0M. Management framed this as evidence of improving margins and operating leverage, arguing that as the unified business scales, profitability should rise alongside revenue growth. ## Early Cross‑Sell Wins Support Bundled Strategy Marchex highlighted several cross‑sell successes that validate its bundled offering. A home‑services client lifted annualized revenue from about $500K to more than $1M after adopting AI‑verified outcomes, while an auto‑services pilot expanded from 40 to 60 locations with potential to reach at least $1M from over $300K today, and an ad‑media customer could increase revenue by more than 50% if a pilot scales. ## Installed Base Offers Significant Upside Potential Management emphasized a large expansion opportunity inside its current customer base, noting the top 100 customers account for roughly 90% of revenue. Within that group, a double‑digit number of clients could each generate incremental seven‑figure annual revenue, and many are seen as candidates to become multi‑million‑dollar relationships over time. ## Efficiency Efforts And Capital Flexibility The company reported organizational realignment and other expense‑efficiency moves that are lowering operating costs, supported by a low‑CapEx business model and meaningful tax shields from the acquisition. Marchex also retains an authorized 3 million‑share buyback program, while insiders hold about one‑third of the equity, aligning management with shareholder outcomes. ## Long‑Term Ambitions And Rule Of 30–40 Target Executives reiterated an ambition to grow Marchex into a business with more than $100M in annual revenue over time. They also highlighted a goal to achieve a Rule of 30 to Rule of 40 profile, blending revenue growth rates with adjusted EBITDA margins as a key yardstick for scalable financial performance. ## Near‑Term Cash Decline And Acquisition Costs Marchex ended Q2 with $8.2M in cash, down from $9.0M at the end of Q1, an 8.9% decline. The drop was mainly tied to transaction expenses and organizational realignment and efficiency initiatives related to the Archenia deal, underscoring that integration carries up‑front costs before synergy benefits fully materialize. ## Acquisition Costs Partially Offset Efficiency Gains While the company reported progress on operating efficiency, benefits in Q2 were partly offset by acquisition‑related costs. Because the Archenia transaction closed on July 1, its financial contribution is absent from Q2, but several deal‑related expenses are already flowing through, tempering the near‑term margin picture. ## Customer Concentration Adds Revenue Risk Management noted that approximately 90% of revenue comes from the top 100 customers, creating concentration risk if renewals or cross‑sell efforts underperform. Investors will need to monitor whether Marchex can deepen relationships and diversify across its base rather than relying heavily on a relatively small set of large accounts. ## Pilot Conversion And Execution Risks Many of Marchex’s new bundled offerings are still in pilot or early rollout stages, and executives stressed that success hinges on converting these paid pilots into recurring, scaled deployments. Failure to demonstrate clear, measurable value could limit growth, making execution and customer outcomes critical to delivering on the company’s ambitious targets. ## Q2 Results Understate Combined Operating Base Because Q2 figures exclude Archenia entirely, management argued that current reported results understate the company’s true operating base. Near‑term performance will therefore depend on integrating Archenia smoothly and realizing the promised revenue synergies and margin improvements from the unified platform. ## Market Uncertainties Still Loom Executives acknowledged that Marchex operates in a rapidly evolving market environment, with uncertainties that could cause actual results to differ from expectations. Macro conditions and execution challenges remain potential downside drivers, even as the company pursues aggressive growth and efficiency plans. ## Guidance Highlights Aggressive Q3 Growth And Margin Goals Looking ahead, Marchex guided Q3 revenue to $16.0M–$16.5M and adjusted EBITDA to $2.3M–$2.5M, reflecting a full quarter of Archenia and expected margin gains from a lower cost base. Management reiterated its focus on upselling top‑100 customers, flagged multiple examples of seven‑figure and multi‑million expansion opportunities, and plans to share Q4 and initial 2027 outlooks in early November. Marchex’s earnings call painted a picture of a company in transition, using the Archenia acquisition to chase scale and higher profitability while taking on integration and concentration risks. For investors, the near‑term story hinges on whether the strong Q3 guidance, pilot conversions and efficiency gains can be delivered, setting Marchex on the path toward its $100M‑plus ambition and Rule‑of‑30–40 financial profile. ### Related Stocks - [MCHX.US](https://longbridge.com/en/quote/MCHX.US.md) ## Related News & Research - [MCHX: Q2 2026 saw improved profitability and strong early momentum from the Archenia acquisition](https://longbridge.com/en/news/295706570.md) - [Marchex (MCHX) Receives a Buy from Northland Securities](https://longbridge.com/en/news/295810897.md) - [Marchex issues $10 million convertible notes to fund Archenia acquisition](https://longbridge.com/en/news/291458085.md) - [Russell C. Horowitz Discloses Investment at Marchex with 18.5% Stake](https://longbridge.com/en/news/291980212.md) - [Top Executive Makes High-Profile Move With Major Arch Capital Group Stock Sale](https://longbridge.com/en/news/296565631.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**